CCDC134
Basic information
Region (hg38): 22:41800679-41832164
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 8.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_024821.5 | NP_079097.1 | 6 | yes | - |
ENST00000255784.6 | ENSP00000255784.5 | 6 | yes | - |
NM_001304797.2 | NP_001291726.1 | 3 | - | - |
NM_001382346.1 | NP_001369275.1 | 6 | - | - |
Phenotypes
GenCC
Source:
- osteogenesis imperfecta (Limited), mode of inheritance: AR
- osteogenesis imperfecta, IIA 22 (Limited), mode of inheritance: AR
- osteogenesis imperfecta, IIA 22 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Osteogenesis imperfecta, type XXII | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 32181939; 34204301; 35019224 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (33 variants)
- Osteogenesis_imperfecta,_IIA_22 (3 variants)
- not_provided (3 variants)
- CCDC134-related_condition (1 variants)
- Recurrent_fractures (1 variants)
- Severe_progressive_deforming_recessive_osteogenesis_imperfecta_(type_III) (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCDC134 gene is commonly pathogenic or not. These statistics are base on transcript: NM_024821.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 32 | 1 | 33 | |||
| nonsense | 1 | 1 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 1 | 0 | 36 | 2 | 0 |
Highest pathogenic variant AF is 0.0000030982735
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CCDC134 | protein_coding | protein_coding | ENST00000255784 | 6 | 25621 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125725 | 0 | 23 | 125748 | 0.0000915 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.0120 | 136 | 136 | 0.997 | 0.00000813 | 1517 |
| Missense in Polyphen | 63 | 67.245 | 0.93687 | 721 | ||
| Synonymous | 0.644 | 51 | 57.2 | 0.892 | 0.00000340 | 444 |
| Loss of Function | 0.252 | 10 | 10.9 | 0.918 | 5.49e-7 | 120 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000904 | 0.0000904 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.000106 | 0.000105 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.000229 | 0.000229 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: In extracellular secreted form, promotes proliferation and activation of CD8(+) T cells, suggesting a cytokine-like function (PubMed:25125657). Enhances cytotoxic anti-tumor activity of CD8(+) T cells (PubMed:25125657). May inhibit ERK and JNK signaling activity (PubMed:18087676, PubMed:23070808). May suppress cell migration and invasion activity, via its effects on ERK and JNK signaling (PubMed:23070808). {ECO:0000269|PubMed:18087676, ECO:0000269|PubMed:23070808, ECO:0000269|PubMed:25125657}.;
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.373
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.37
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.335
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- Cellular component
- extracellular region;nucleus;endoplasmic reticulum;membrane
- Molecular function
- protein binding